McDowell Lachlan, Rischin Danny, Gough Karla, Henson Christina
Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
Front Oncol. 2022 Feb 15;12:834068. doi: 10.3389/fonc.2022.834068. eCollection 2022.
Head and neck squamous cell carcinoma (HNSCC) is the most common cancer involving the mucosal surfaces of the head and neck and is associated with a number of etiological factors, including cigarette smoking, alcohol and betel nut consumption and exposure to high-risk human papillomavirus. The risk of HNSCC increases with age, peaking in the seventh and eighth decade, but this varies by anatomical and histological subtype. While several advancements have been made in the treatment of head and neck cancer (HNC) in recent decades, undertaking curative treatment still subjects the majority of HNSCC patients to substantial treatment-related toxicity requiring patients to tolerate a gamut of physical, psychological, and emotional demands on their reserves. In conjunction with other patient-related factors, clinicians involved in treating patients with HNSCC may incorporate advancing chronological age into their decision-making process when determining treatment recommendations. While advancing chronological age may be associated with increased concerns regarding physical treatment tolerability, clinicians may also be concerned about heightened vulnerability in various health and wellbeing outcomes. The available literature, however, does not provide evidence of this vulnerability in patients with advancing age, and, in many instances, older patients self-report greater resilience compared to their younger counterparts. While this data is reassuring it is limited by selection bias and heterogeneity in trial and study design and the absence of a consistent definition of the elderly patient with HNSCC. This narrative review article also includes a review of the measures used to assess HRQL, psychosocial outcomes and unmet needs in elderly or older patients with HNSCC.
头颈部鳞状细胞癌(HNSCC)是最常见的累及头颈部黏膜表面的癌症,与多种病因相关,包括吸烟、饮酒、食用槟榔以及接触高危型人乳头瘤病毒。HNSCC的风险随年龄增长而增加,在七十和八十岁时达到峰值,但这因解剖学和组织学亚型而异。尽管近几十年来头颈部癌(HNC)的治疗取得了一些进展,但进行根治性治疗仍使大多数HNSCC患者承受大量与治疗相关的毒性,这要求患者在身体、心理和情感方面承受一系列的负担。在考虑其他与患者相关的因素时,参与治疗HNSCC患者的临床医生在确定治疗建议时,可能会将实际年龄的增长纳入其决策过程。虽然实际年龄的增长可能与对身体治疗耐受性的担忧增加有关,但临床医生也可能担心在各种健康和幸福结局方面的脆弱性增加。然而,现有文献并未提供证据证明年龄增长的患者存在这种脆弱性,而且在许多情况下,老年患者自我报告的恢复力比年轻患者更强。尽管这些数据令人安心,但它受到试验和研究设计中的选择偏倚和异质性以及缺乏对老年HNSCC患者的一致定义的限制。这篇叙述性综述文章还包括对用于评估老年或年长HNSCC患者的健康相关生活质量、心理社会结局和未满足需求的措施的综述。